Insider · CIK 0001860876
Michele Farmer
Files at PACB (PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). First filing Feb 19, 2025, latest May 21, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PACB: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | PACBsell PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $5,200 5,195 shares | -2% | 0% from low-62% from high | |
| 23Weak | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $4,183 2,973 shares | -2% | - | |
| 34Weak | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $46k 24,349 shares | -11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 19, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -5,195 | $1.00 | $5,200 | 269,259 | May 21, 2025 |
| Mar 19, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Common Stock | +89,835 | $0.00 | $0 | 274,454 | Mar 21, 2025 |
| Mar 19, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Stock Option (right to buy)derivative | +179,670 | $0.00 | $0 | 179,670 | Mar 21, 2025 |
| Mar 3, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -2,973 | $1.41 | $4,183 | 184,619 | Mar 5, 2025 |
| Feb 18, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -24,349 | $1.88 | $46k | 187,592 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.